248 related articles for article (PubMed ID: 8239673)
1. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action.
Freeman AJ; Cunningham KT; Tyers MB
Anticancer Drugs; 1992 Apr; 3(2):79-85. PubMed ID: 1525396
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and anti-emetic properties of ondansetron.
Tyers MB; Bunce KT; Humphrey PP
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894
[TBL] [Abstract][Full Text] [Related]
4. [Value of 5-HT3 receptor antagonists, particularly as anti-emetic drugs].
Lechat P
Ann Pharm Fr; 1991; 49(6):307-16. PubMed ID: 1842169
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Cunningham RS
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
[TBL] [Abstract][Full Text] [Related]
7. [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].
d'Allens H; Aubert B; Bons J; Pappo M
Bull Cancer; 1991; 78(12):1139-46. PubMed ID: 1838490
[TBL] [Abstract][Full Text] [Related]
8. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
Perez EA
Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
[TBL] [Abstract][Full Text] [Related]
9. [An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2276-81. PubMed ID: 8259839
[TBL] [Abstract][Full Text] [Related]
10. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.
Tyers MB; Freeman AJ
Oncology; 1992; 49(4):263-8. PubMed ID: 1387926
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of ondansetron.
Naylor RJ; Rudd JA
Eur J Anaesthesiol Suppl; 1992 Nov; 6():3-10. PubMed ID: 1425623
[TBL] [Abstract][Full Text] [Related]
13. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
14. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].
Csáki C; Ferencz T; Koós R; Schuler D; Borsi J
Orv Hetil; 1993 Jun; 134(25):1363-7. PubMed ID: 8332356
[TBL] [Abstract][Full Text] [Related]
15. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
16. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
Constenla M
Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
[TBL] [Abstract][Full Text] [Related]
18. Emesis and anti-emesis.
Naylor RJ; Rudd JA
Cancer Surv; 1994; 21():117-35. PubMed ID: 8564988
[TBL] [Abstract][Full Text] [Related]
19. Antiemetics.
Allan SG
Gastroenterol Clin North Am; 1992 Sep; 21(3):597-611. PubMed ID: 1355467
[TBL] [Abstract][Full Text] [Related]
20. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
